Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy
Year: 2014
Type: review
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: PD-1/PD-L1 pathway, cancer immunotherapy, immune checkpoint inhibitors, nivolumab, pembrolizumab, atezolizumab, durvalumab, CTLA-4 blockade, immune-related adverse events, immune-related pneumonitis, immune-related colitis, melanoma, renal cell carcinoma, non-small cell lung cancer, clinical efficacy and safety
Open Access status: closed
OpenAlex ID: W1979401452
